e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Bronchiectasis and NTM infections: clinical aspects and research outlook
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype
Melissa McDonnell (Galway, Ireland), Melissa McDonnell, O’Mahony Michael, Breen David, O’Regan Anthony, Rutherford Robert
Source:
International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Session:
Bronchiectasis and NTM infections: clinical aspects and research outlook
Session type:
Poster Discussion
Number:
366
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Melissa McDonnell (Galway, Ireland), Melissa McDonnell, O’Mahony Michael, Breen David, O’Regan Anthony, Rutherford Robert. Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype. Eur Respir J 2015; 46: Suppl. 59, 366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Presence of aspiration pneumonia is independently associated with mortality, after adjusting for age, disease severity, and comorbities
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Coagulation activity increases with disease severity in patients with asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Late Breaking Abstract - Dysbiosis in the lung microbiome of patients with HIV and pneumonia is associated with worse disease severity and mortality scores
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Mortality and survival predictor in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Bronchiectasis is common in severe asthma
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Abnormal heart rate variability in patients with bronchiectasis
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Anaemia in COPD: mortality and disease severity
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006
Determinants and assessment of excess cardiovascular risk in bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept